After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meeting.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
FibroGen Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $0.89 and fluctuated between $0.9000 as its day high and $0.8302 as its day low. The current market capitalization of FibroGen Inc is $87.77M. A total of 1.03 million shares were traded on the day, compared to an average of 1.75M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, FGEN has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 22,660 shares. Over the last 12 months, there were 25 BUYs and 63 SELLs from insiders. Insiders purchased 758,136 shares during that period but sold 249,513.
In the most recent transaction, Henderson Jeffrey William sold 2,000 shares of FGEN for 1.03 per share on Sep 01. After the transaction, the Director now owns 28,866 company shares. In a previous transaction on Aug 04, Henderson Jeffrey William sold 2,000 shares at 1.91 per share. FGEN shares that Director owns now total 30,866.
Among the insiders who sold shares, Henderson Jeffrey William disposed of 2,000 shares on Jul 11 at a per-share price of $2.69. This resulted in the Director holding 32,866 shares of FGEN after the transaction. In another insider transaction, Conterno Enrique A sold 1,880 shares at $2.80 per share on Jul 07. Company shares held by the Chief Executive Officer now total 374,722.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for FGEN in the last 3 months, the mean price target is $0.50 with high estimates of $0.50 and low estimates of $0.50. In terms of 52-week highs and lows, FGEN has a high of $25.69 and a low of $0.33.
As of this writing, FGEN has an earnings estimate of $Compugen Ltd. per share for the current quarter. EPS was calculated based on a consensus of Agenus Inc. estimates, with a high estimate of $FibroGen, Inc per share and a lower estimate of $Gen Digital Inc.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. FGEN’s latest balance sheet shows that the firm has $405.19M in Cash & Short Term Investments as of fiscal 2021. There were $99.72M in debt and $225.50M in liabilities at the time. Its Book Value Per Share was -$1.60, while its Total Shareholder’s Equity was $229.11M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FGEN is Buy with a score of 2.25.
